Cesca Appoints CFO
This article was originally published in Scrip
Cesca Therapeutics Inc., an autologous cell-based regenerative medicine company, has appointed Michael Bruch chief financial officer (CFO). Bruch joined the company as controller in 2003 and he was appointed interim CFO in May 2015. He has over 25 years of experience in various financial and managerial roles at companies including General Electric and Dada Micro Scan (now Siemens Healthcare).